<DOC>
	<DOC>NCT00229476</DOC>
	<brief_summary>The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.</brief_summary>
	<brief_title>Study of Medication and Placebo Response in Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Clinical Diagnosis of Unipolar Major Depression Substance Abuse, Psychotic Disorder, History of Severe Head Trauma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>EEG</keyword>
	<keyword>QEEG</keyword>
	<keyword>cordance</keyword>
	<keyword>Zoloft</keyword>
	<keyword>sertraline</keyword>
	<keyword>placebo</keyword>
	<keyword>electroencephalogram</keyword>
	<keyword>brain</keyword>
	<keyword>antidepressants</keyword>
</DOC>